全球体液采集与诊断市场规模、份额、趋势及成长分析报告（2026-2034年）

预计体液采集和诊断的市场规模将从 2025 年的 400.7 亿美元成长到 2034 年的 733 亿美元，2026 年至 2034 年的复合年增长率为 6.94%。

受对精准早期疾病诊断需求不断增长的推动，全球体液采集和诊断市场正经历强劲增长。血液、尿液、脑脊髓液和唾液等体液在检测多种疾病方面发挥着至关重要的作用。人们对预防医学和定期体检的日益重视，促进了诊断检测的普及。全球诊断实验室和医院的扩张也推动了市场发展。

主要驱动因素包括糖尿病、癌症和心血管疾病等慢性病盛行率的上升。诊断设备和微创采样方法的技术进步提高了患者的舒适度和检测准确性。就地检验解决方案的日益普及进一步加速了市场成长。此外，新兴国家政府为加强医疗基础设施所做的努力也有助于提高诊断服务的可近性。

由于分子诊断和自动化检测系统的持续创新，市场前景仍然乐观。数位健康技术和数据分析的融合有望提高诊断准确性。各公司正致力于研发速度更快、成本更低的检测套组。随着医疗系统日益重视早期检测和个人化医疗，体液诊断的需求预计将持续稳定成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球体液采集与诊断市场：依样本类型划分

• 市场分析、洞察与预测
• 血
• 唾液
• 尿
• 脑脊髓液

第五章 全球体液采集与诊断市场：依产品分类

• 市场分析、洞察与预测
• 测试和服务
• 试剂盒和耗材
• 装置

第六章 全球体液采集与诊断市场：依技术划分

• 市场分析、洞察与预测
• 次世代定序
• 聚合酵素链锁反应（PCR）
• 萤光原位杂合反应（FISH）
• 其他的

第七章 全球体液采集与诊断市场：依应用领域划分

• 市场分析、洞察与预测
• 诊断和监测
• 治疗方案製定
• 预后诊断和筛检

第八章 全球体液采集与诊断市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • Bio-Rad Laboratories
  • Illumina Inc
  • Guardant Health
  • Qiagen
  • Johnson & Johnson
  • Laboratory Corporation Of America Holdings
  • Biocept Inc
  • F. Hoffmann-La Roche Ltd
  • MDxHealth SA

The Body Fluid Collection And Diagnostics Market size is expected to reach USD 73.30 Billion in 2034 from USD 40.07 Billion (2025) growing at a CAGR of 6.94% during 2026-2034.

The Global Body Fluid Collection and Diagnostics Market is witnessing strong growth due to the increasing demand for accurate and early disease diagnosis. Body fluids such as blood, urine, cerebrospinal fluid, and saliva play a crucial role in detecting various medical conditions. Growing awareness about preventive healthcare and routine health check-ups is boosting the use of diagnostic tests. The expansion of diagnostic laboratories and hospitals worldwide is also contributing to market development.

Key drivers include the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders. Technological advancements in diagnostic equipment and minimally invasive collection methods are improving patient comfort and test accuracy. The increasing adoption of point-of-care testing solutions is further accelerating market growth. Additionally, government initiatives to strengthen healthcare infrastructure in emerging countries are expanding access to diagnostic services.

Future prospects for this market remain promising, with continuous innovation in molecular diagnostics and automated laboratory systems. The integration of digital health technologies and data analytics is expected to improve diagnostic precision. Companies are investing in the development of faster and more cost-effective testing kits. As healthcare systems emphasize early detection and personalized medicine, the demand for body fluid diagnostics will continue to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Sample

• Blood
• Saliva
• Urine
• Cerebrospinal Fluid

By Product

• Tests/Services
• Kits & Consumables
• Instruments

By Technology

• Next Generation Sequencing
• Polymerase Chain Reaction (PCR)
• Fluorescence in situ hybridization (FISH)
• Others

By Application

• Diagnostics & Monitoring
• Therapeutic Decision Making
• Prognostics & Screening

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, BioRad Laboratories, Illumina Inc, Guardant Health, Qiagen, Johnson Johnson, Laboratory Corporation of America Holdings, Biocept Inc, F HoffmannLa Roche Ltd, MDxHealth SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY SAMPLE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Sample
• 4.2. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Saliva Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cerebrospinal Fluid Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Tests/Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Kits & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Next Generation Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Polymerase Chain Reaction (PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Fluorescence in situ hybridization (FISH) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Diagnostics & Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Therapeutic Decision Making Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Prognostics & Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Sample
  • 8.2.2 By Product
  • 8.2.3 By Technology
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Sample
  • 8.3.2 By Product
  • 8.3.3 By Technology
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Sample
  • 8.4.2 By Product
  • 8.4.3 By Technology
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Sample
  • 8.5.2 By Product
  • 8.5.3 By Technology
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Sample
  • 8.6.2 By Product
  • 8.6.3 By Technology
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Bio-Rad Laboratories
  • 10.2.3 Illumina Inc
  • 10.2.4 Guardant Health
  • 10.2.5 Qiagen
  • 10.2.6 Johnson & Johnson
  • 10.2.7 Laboratory Corporation Of America Holdings
  • 10.2.8 Biocept Inc
  • 10.2.9 F. Hoffmann-La Roche Ltd
  • 10.2.10 MDxHealth SA